Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC – Get Free Report)’s stock price dropped 1.4% during trading on Wednesday . The company traded as low as $0.4950 and last traded at $0.4950. Approximately 719,226 shares changed hands during mid-day trading, an increase of 3,079% from the average daily volume of 22,626 shares. The stock had previously closed at $0.5020.
Bellevue Life Sciences Acquisition Price Performance
The business’s 50-day simple moving average is $0.54 and its 200 day simple moving average is $0.58.
About Bellevue Life Sciences Acquisition
Bellevue Life Sciences Acquisition Corp. (NASDAQ: BLAC) is a special purpose acquisition company organized as a Delaware corporation. The company completed its initial public offering in 2021, raising gross proceeds to pursue a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more life sciences businesses.
BLAC’s principal activity is to identify and complete a business combination with a target operating company in the life sciences sector.
See Also
- Five stocks we like better than Bellevue Life Sciences Acquisition
- Abercrombie Rallies as Strong Q1 Earnings Extend Winning Streak
- TeraWulf Bets on Power Infrastructure to Lead AI Build-Out
- Amazon’s Alexa for Shopping Strengthens an Already Strong Bull Case
- Keysight: The AI and Defense Stock Seeing Big Price Target Boosts
Receive News & Ratings for Bellevue Life Sciences Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellevue Life Sciences Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
